In addition, FGFR2 fusions occur in cholangiocarcinoma, lung squamous cell carcinoma (LSCC), thyroid cancer, prostate cancer, according to a study of FGFR targetable gene fusions (Wu et al., 2013). Here, FGFR2 is linked to cholangiocarcinoma.